InMed is a clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. InMed's proprietary platform technology, product pipeline and accelerated development pathway are the fundamental value drivers of the company.
#350-409 Granville Street, Vancouver, BC CA
UPLOAD NEW PRESS RELEASE (log in required)
Log in to upload press releases
INMED PHARMACEUTICALS Q&A
If you have any questions about InMed Pharmaceuticals or any of their products, please post them here.